UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000005934
Receipt number	R000007015
Scientific Title	Phase II Trial of Erlotinib Plus Bevacizumab for Patients with Advanced Non-Small-Cell Lung Cancer Who harboring EGFR mutation.
Date of disclosure of the study information	2011/07/05
Last modified on	2011/07/05 21:49:02

---